News
Brief news reports on Tuberculosis
By
WHO/Europe
Published: June 3, 2015, 10:43 p.m.·
Tags:
Drug-resistant TB
In September 2011 the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011–2015 and its accompanying resolution EUR/R61/R7 were endorsed at the sixty-first session of the Regional Committee (Baku, Azerbaijan, 12–15 September 2011).
Read More →
By
Madeleine Johnson
Published: June 3, 2015, 10:22 p.m.·
Tags:
Diagnostics
NEW YORK (GenomeWeb) – Even with concessionary pricing and international investment, the cost of Cepheid's GeneXpert MTB/RIF for Mycobacterium tuberculosis and rifampin resistance testing sometimes strains impoverished areas.
Read More →
By
Jennifer Southall
Published: June 3, 2015, 10:10 p.m.·
Tags:
Pediatrics,
Diagnostics
Tuberculin skin testing resulted in poorer specificity when compared with a commercial interferon-gamma release assay in identifying latent tuberculosis among a cohort of internationally adopted children.
Read More →
By
Ricki Lewis
Published: June 3, 2015, 9:54 p.m.·
Tags:
Pediatrics,
Drug-resistant TB
Isoniazid-resistant tuberculosis (TB) is more common than had been thought among children, particularly in Europe, according to the results of a study published online June 1 in Pediatrics.
Read More →
By
Kwame Buist
Published: June 3, 2015, 9:28 p.m.·
Tags:
Access,
Advocacy
JOHANNESBURG, Jun 3 2015 (IPS) - Patient and leading health organisations in South Africa have now joined a Fix the Patent Laws campaign launched in 2011 by Treatment Action Campaign (TAC) and Doctors Without Borders (MSF) to push for reform of the country’s current patent laws.
Read More →
By
Ecole Polytechnique Fédérale de Lausanne
Published: June 3, 2015, 9:20 p.m.·
Tags:
Scientific research
03.06.15 - Scientists at EPFL have discovered how the tuberculosis bacterium can trick the patient’s immune cells to lower their defenses.
Read More →
By
UT Southwestern Medical Center
Published: June 3, 2015, 8:55 p.m.·
Tags:
Scientific research
DALLAS – June 2, 2015 – A study by researchers at UT Southwestern Medical Center has identified how an enzyme involved in protecting the body from pathogens senses Mycobacterium tuberculosis (TB), a bacterial pathogen that infects millions of people worldwide and causes about 1.5 million deaths annually.
Read More →
By
Antigone Barton
Published: June 2, 2015, 12:46 p.m.·
Tags:
Medicines,
Research and development
Populations with needs that can and do affect the impacts of tuberculosis treatments are among the most vulnerable to the disease, make up significant proportions of the total of people sick with the disease worldwide, but are also the most neglected in TB drug development efforts. An article in a recently released Journal of Infectious Diseases supplement on tuberculosis drug development explores the challenges that developing products of appropriate doses and formulations for children, people with HIV, people with diabetes and pregnant women as well as the opportunities that meeting those challenges present.
Read More →
By
Aaron Reeves et al.
Published: June 1, 2015, 10:33 p.m.·
Tags:
TB programs
Read More →
By
Michel Kazatchkine
Published: June 1, 2015, 10:13 p.m.·
Tags:
Global TB response
After recently returning from a ministerial conference on tuberculosis (TB) and multi-drug resistant TB held on the initiative of the Latvian Presidency of the European Union, I am encouraged that our political elites are eventually deciding to commit to eradicate—rather than to only “control”—TB, the world biggest killing curable disease.
Read More →
Page 545 of 878 · Total posts: 10
←First
544
545
546
Last→